Dexco S.A. (DXCO3)
Sao Paulo Exchange · Brazil · prices in BRL · close of 16 Oct 2026
Key indicators
| Last close | BRL 7.440 |
|---|---|
| 52-week range | 4.450 – 7.800 |
| Return, 1 month / 3 months | +33.6% / +43.9% |
| Return, 1 year / 3 years | +65.0% / +24.8% |
| Trend | Uptrend |
| RSI (14) | 82 |
| Volatility (1 year) | 34.6% |
| Worst drawdown (1 year) | -26.8% |
| Average daily value traded | 17.41M BRL |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Dexco is a Brazilian manufacturer of building materials based in Sao Paulo. It makes wood panels used in furniture and construction, ceramic tiles for floors and walls, and metal fittings and fixtures for bathrooms and kitchens. The company also manages planted forests that supply its wood-based production. Its customers include furniture makers, builders, retailers and construction companies, and it serves markets in Brazil and abroad through its industrial divisions.
The shares are listed on the Sao Paulo Exchange in Brazil under the code DXCO3, and the price on this page is in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Dexco S.A. (DXCO3) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 7.440 on 16 October 2026.
Its price-based Market X-Ray is 79 out of 100 (a strong price profile), ranking 28 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 65.0% and over the last three months it rose 43.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 88 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 40.5% | ||
| From 52-week high | -2.9% | ||
| Momentum | 86 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 43.9% | ||
| 6-month return | 28.3% | ||
| 12-month return, skipping the last month | 23.5% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 34.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.8% | ||
| Liquidity | 89 · Strong | Trades actively. | |
| Average daily value traded | 17.41M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −2.9% |
|---|---|
| 1 month | +33.6% |
| 3 months | +43.9% |
| 6 months | +28.3% |
| 1 year | +65.0% |
| 3 years | +24.8% |
| 5 years | −34.3% |
Signals
| 50-day / 200-day average | 5.745 / 5.295 |
|---|---|
| Golden / death cross (60 days) | Golden, 26 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.292 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Mar 2025 | BRL 0.0084 |
| 18 Dec 2024 | BRL 0.0518 |
| 12 Mar 2024 | BRL 0.0800 |
| 19 Dec 2023 | BRL 0.2412 |
| 14 Dec 2022 | BRL 0.4177 |
| 14 Dec 2021 | BRL 1.7356 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.